Transient myeloproliferative disorder with a CD7+ and CD56+ myeloid/natural killer cell precursor phenotype in a newborn.

Anewborn with a transient myeloproliferative disorder and a myeloid/natural killer cell leukemia phenotype is described. The blasts expressed CD7, CD33, CD34, CD56, and CD117 but did not react with cytoplasmic myeloperoxidase and were negative for cy CD22, HLA-DR, and CD90 expression. No megakaryoblastic surface markers were identified. The blast population disappeared from the peripheral blood and bone marrow within 2 months, but hepatomegaly and recurrent respiratory insufficiency persisted. The patient died of unilateral pneumonia in the third month of life. Neither extramedullary infiltration nor other hematologic signs of disease progression were found.

[1]  B. Granzen,et al.  Transient myeloproliferative disorder with 11q23 aberration in two neonates with Down syndrome , 1998, Annals of Hematology.

[2]  鈴木 律朗.  CD7[+] and CD56[+] myeloid/natural killer cell precursor acute leukemia : a distinct hematolymphoid disease entity , 1998 .

[3]  H. Saito,et al.  CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. , 1997, Blood.

[4]  I. Miura,et al.  Cerebellar myeloblastoma formation in CD7-positive, neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia (M1) , 1997, Annals of Hematology.

[5]  A. Zipursky,et al.  Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome. , 1997, Seminars in perinatology.

[6]  N. Yagihashi,et al.  Transient abnormal myelopoiesis accompanied by hepatic fibrosis in two infants with Down syndrome. , 1995, Journal of clinical pathology.

[7]  D. Arthur,et al.  Acute leukemia and the transient myeloproliferative disorder associated with Down syndrome: morphologic, immunophenotypic and cytogenetic manifestations. , 1995, Leukemia.

[8]  J. Rowley,et al.  Detection of 11q23/MLL rearrangements in infant leukemias with fluorescence in situ hybridization and molecular analysis. , 1995, Leukemia.

[9]  P. Zubizarreta,et al.  Transient myeloproliferative disorder associated with trisomy 21, a wide range syndrome: report of two cases with trisomy 21 mosaicism. , 1995, Medical and pediatric oncology.

[10]  J. Cotelingam,et al.  Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without down syndrome , 1994, American journal of hematology.

[11]  M. Grever,et al.  HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. , 1994, Blood.

[12]  A. Homans,et al.  Transient abnormal myelopoiesis of infancy associated with trisomy 21. , 1993, The American journal of pediatric hematology/oncology.

[13]  Y. Tsunematsu,et al.  Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: a report of four autopsy cases and proposal of a hypothesis. , 1992, Blood.

[14]  P. Darbyshire,et al.  Transient myeloproliferative disorder in Down's syndrome: three cases with megakaryocytic markers. , 1991, Pediatric hematology and oncology.

[15]  H. Kurahashi,et al.  Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome. , 1991, Blood.

[16]  W. Tarnow-Mordi,et al.  Trisomy 21 in transient myeloproliferative disorder. , 1990, Cancer genetics and cytogenetics.